Complete Filing Data
Invesco Galaxy Ethereum ETF reported Stockholders Equity of $25.85 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Invesco Galaxy Ethereum ETF did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | -$1.8M |
| Operating Income Loss | -$65.0K |
| Operating Expenses | $65.0K |
| Operating Expenses Net |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Net Income Loss | $14.1M | $5.5M | -$11.4M | -$3.5M | $0.00 |
| Operating Income Loss | -$21.8K | -$11.6K | -$12.4K | -$6.0K | |
| Operating Expenses | $21.8K | $11.6K | $12.4K | $6.0K | |
| Operating Expenses Net | $6.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | $25.8M | $23.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 |
| Stockholders Equity Period Increase Decrease Due To Share Transactions | $4.1M | |
| Stockholders Equity Period Increase Decrease | $2.3M | |
| Unrealized Gain Loss On Investments | -$340.6K | |
| Liabilities | $5.6K | $6.0K |
| Assets Net | $25.8M | $23.6M |
| Assets | $25.9M | $23.6M |
| Retained Earnings Accumulated Deficit | $2.3M | $4.1M |
| Investment Owned Percent Of Net Assets | $1.00 | $1.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $0.00 | |
| Additional Paid In Capital Common Stock | $23.6M | $19.5M |
| Accrued Professional Fees Current And Noncurrent | $5.6K | $6.0K |
| Increase Decrease Accrued Sponsors Fees | -$433.00 | |
| Net Realized Gain Loss On Investments In Ether Sold To For Redemptions | -$1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Stockholders Equity | $39.0M | $22.6M | $13.7M | $20.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stockholders Equity Period Increase Decrease Due To Share Transactions | $2.2M | $3.4M | $1.6M | $23.8M | $100.0K |
| Stockholders Equity Period Increase Decrease | $16.3M | $8.9M | -$9.8M | $20.3M | $100.0K |
| Unrealized Gain Loss On Investments | $13.7M | $5.6M | -$10.6M | -$3.5M | $0.00 |
| Liabilities | $7.5K | $4.7K | $3.4K | $2.6K | $0.00 |
| Assets Net | $39.0M | $22.6M | $13.7M | $20.4M | $100.0K |
| Assets | $39.0M | $22.7M | $13.7M | $20.4M | $100.0K |
| Retained Earnings Accumulated Deficit | $12.3M | -$1.8M | -$7.3M | -$3.5M | |
| Investment Owned Percent Of Net Assets | $1.00 | $1.00 | $1.00 | $1.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $0.00 | $0.00 | $100.0K | ||
| Additional Paid In Capital Common Stock | $26.6M | $24.4M | $21.1M | $23.9M | |
| Accrued Professional Fees Current And Noncurrent | $7.5K | $4.7K | $3.4K | $2.6K | |
| Increase Decrease Accrued Sponsors Fees | -$2.6K | $2.6K | $0.00 | ||
| Net Realized Gain Loss On Investments In Ether Sold To For Redemptions | -$854.1K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Proceeds From Issuance Of Common Stock | $38.9M |
| Net Cash Provided By Used In Operating Activities | -$4.1M |
| Net Cash Provided By Used In Financing Activities | $4.1M |
| Proceeds From Ether Sold For Redemptions | -$34.8M |
| Proceeds From Disposition Of Investment Operating Activity | $65.4K |
| Payments For Repurchase Of Common Stock | $34.8M |
| Payments For Purchase Of Investment Operating Activity | $38.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $3.1M | $24.0M | $100.0K | ||
| Net Cash Provided By Used In Operating Activities | -$1.6M | -$23.9M | $0.00 | ||
| Net Cash Provided By Used In Financing Activities | $1.6M | $23.9M | $100.0K | ||
| Proceeds From Ether Sold For Redemptions | -$24.8M | $0.00 | -$1.5M | $0.00 | |
| Proceeds From Disposition Of Investment Operating Activity | $15.1K | $3.4K | $0.00 | ||
| Payments For Repurchase Of Common Stock | $1.5M | $100.0K | $0.00 | ||
| Payments For Purchase Of Investment Operating Activity | $3.1M | $23.9M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Asset Value Per Share | $29.61 | $33.28 |
| Investment Company Market Value Per Share | $29.59 | $33.39 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Net Asset Value Per Share | $41.35 | $24.81 | $18.24 | $26.02 | $25.00 |
| Investment Company Market Value Per Share | $41.48 | $25.13 | $18.24 | $25.94 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Investment Owned At Fair Value | $25.9M | $23.6M |
| Partners Capital Account Units | $873.0K | $708.0K |
| Unrealized Gain Loss Investment And Derivative Operating After Tax | -$340.6K | |
| Stock Redeemed Or Called During Period Value | $34.8M | |
| Stock Issued During Period Value New Issues | $38.9M | |
| Realized Gain Loss Investment And Derivative Operating After Tax | -$1.4M | |
| Investment Income Net | -$65.0K | |
| Limited Partners Capital Account Units Outstanding | $873.0K | $708.0K |
| Stock Redeemed Or Called During Period Shares | 945.0K | |
| Stock Issued During Period Shares Period Increase Decrease Due To Share Transactions | 165.0K | |
| Stock Issued During Period Shares Period Increase Decrease | 165.0K | |
| Stock Issued During Period Shares New Issues | 1.1M | |
| Sponsor Fees | $65.0K | |
| Realized Investment Gains Losses | -$1.4M | |
| Realized Investment Gain Loss On Sponsor Fee | -$11.1K | |
| Number Of Cyptocurrency | $8.7K | $7.1K |
| Investment Owned At Cost | $22.5M | $19.8M |
| Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency | -$1.7M | |
| Interest And Dividend Income Operating | $0.00 | |
| Realized Investment Gain Loss On Redemptions | -$1.4M | |
| Investment Company Contractual Fee Waived | ||
| Interest Paid Net |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Investment Owned At Fair Value | $39.0M | $22.7M | $13.7M | $20.4M | |
| Partners Capital Account Units | $943.0K | $913.0K | $753.0K | $783.0K | |
| Unrealized Gain Loss Investment And Derivative Operating After Tax | $13.7M | $5.6M | -$10.6M | -$3.5M | $0.00 |
| Stock Redeemed Or Called During Period Value | $24.8M | $0.00 | $1.5M | $100.0K | $0.00 |
| Stock Issued During Period Value New Issues | $27.0M | $3.4M | $3.1M | $23.9M | $100.0K |
| Realized Gain Loss Investment And Derivative Operating After Tax | $436.4K | -$5.0K | -$856.9K | -$1.5K | $0.00 |
| Investment Income Net | -$21.8K | -$11.6K | -$12.4K | -$6.0K | $0.00 |
| Limited Partners Capital Account Units Outstanding | $943.0K | $913.0K | $753.0K | $783.0K | $4.0K |
| Stock Redeemed Or Called During Period Shares | 630.0K | 0.00 | 70.0K | 4.0K | 0.00 |
| Stock Issued During Period Shares Period Increase Decrease Due To Share Transactions | 30.0K | 160.0K | 45.0K | 779.0K | 4.0K |
| Stock Issued During Period Shares Period Increase Decrease | 30.0K | 160.0K | 45.0K | 779.0K | 4.0K |
| Stock Issued During Period Shares New Issues | 660.0K | 160.0K | 115.0K | 783.0K | 4.0K |
| Sponsor Fees | $21.8K | $11.6K | $12.4K | $6.0K | |
| Realized Investment Gains Losses | $436.4K | -$5.0K | -$856.9K | -$1.5K | |
| Realized Investment Gain Loss On Sponsor Fee | -$1.4K | -$5.0K | -$2.9K | -$1.5K | $0.00 |
| Number Of Cyptocurrency | $9.4K | $9.1K | $7.5K | $7.8K | |
| Investment Owned At Cost | $26.6M | $23.9M | $20.6M | $23.9M | |
| Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency | $14.2M | $5.6M | -$11.4M | -$3.5M | |
| Interest And Dividend Income Operating | $0.00 | $0.00 | $0.00 | $0.00 | |
| Realized Investment Gain Loss On Redemptions | $437.9K | $0.00 | -$854.1K | $0.00 | |
| Investment Company Contractual Fee Waived | $0.00 | ||||
| Interest Paid Net | $0.00 |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.